Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.09 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (tuft cells) | 0.10 |
| chemistry Open Targets | compounds already reach it: lefitolimod, hydroxychloroquine sulfate, bazlitoran +8 | 1.00 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 21 Parkinson's papers of 7,178 | 0.59 |
| pathways Reactome | 7 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 2843
Sealed predictions
- TLR9 in dopamine neurons, braakn/a → n/areceipt 2850
Swarm cases
receipt 2850: TLR9 in dopamine neurons, braak
- cell type
- TLR9 is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TLR9 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts